HRPK20040930B3 - Acyl-4-carboxyphenylurea derivatives, method for production and use thereof - Google Patents
Acyl-4-carboxyphenylurea derivatives, method for production and use thereofInfo
- Publication number
- HRPK20040930B3 HRPK20040930B3 HR20040930A HRP20040930A HRPK20040930B3 HR PK20040930 B3 HRPK20040930 B3 HR PK20040930B3 HR 20040930 A HR20040930 A HR 20040930A HR P20040930 A HRP20040930 A HR P20040930A HR PK20040930 B3 HRPK20040930 B3 HR PK20040930B3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- cycloalkyl
- alkynyl
- alkenyl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10215907A DE10215907A1 (de) | 2002-04-11 | 2002-04-11 | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
PCT/EP2003/003251 WO2003084922A1 (de) | 2002-04-11 | 2003-03-28 | Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20040930A2 HRP20040930A2 (en) | 2005-04-30 |
HRPK20040930B3 true HRPK20040930B3 (en) | 2006-09-30 |
Family
ID=28684935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040930A HRPK20040930B3 (en) | 2002-04-11 | 2004-10-07 | Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP1497262B1 (xx) |
JP (1) | JP4328211B2 (xx) |
KR (1) | KR20040097333A (xx) |
CN (1) | CN1286805C (xx) |
AR (1) | AR039403A1 (xx) |
AT (1) | ATE476412T1 (xx) |
AU (1) | AU2003216900A1 (xx) |
BR (1) | BR0309242A (xx) |
CA (1) | CA2481817A1 (xx) |
DE (2) | DE10215907A1 (xx) |
EC (1) | ECSP045347A (xx) |
HR (1) | HRPK20040930B3 (xx) |
HU (1) | HUP0500440A2 (xx) |
IL (1) | IL164249A0 (xx) |
MA (1) | MA26390A1 (xx) |
MX (1) | MXPA04009468A (xx) |
NO (1) | NO20044882L (xx) |
NZ (1) | NZ535834A (xx) |
OA (1) | OA12805A (xx) |
PA (1) | PA8570901A1 (xx) |
PE (1) | PE20040374A1 (xx) |
PL (1) | PL371279A1 (xx) |
RU (1) | RU2004133045A (xx) |
TN (1) | TNSN04199A1 (xx) |
TW (1) | TW200404762A (xx) |
UA (1) | UA78040C2 (xx) |
UY (1) | UY27761A1 (xx) |
WO (1) | WO2003084922A1 (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10306502B4 (de) * | 2003-02-17 | 2005-03-17 | Aventis Pharma Deutschland Gmbh | Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel |
DE10308351A1 (de) | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE10308352A1 (de) | 2003-02-27 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
DE10308353A1 (de) | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE10309929B4 (de) * | 2003-03-07 | 2006-02-23 | Sanofi-Aventis Deutschland Gmbh | Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
US7501440B2 (en) | 2003-03-07 | 2009-03-10 | Sanofi-Aventis Deutschland Gmbh | Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use |
US7241787B2 (en) | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
EP1586573B1 (en) | 2004-04-01 | 2007-02-07 | Sanofi-Aventis Deutschland GmbH | Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
DE102005026762A1 (de) | 2005-06-09 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
NZ566877A (en) | 2005-09-29 | 2010-05-28 | Sanofi Aventis | Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
MX2009001043A (es) | 2006-08-08 | 2009-02-06 | Sanofi Aventis | Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso. |
DE102007005045B4 (de) | 2007-01-26 | 2008-12-18 | Sanofi-Aventis | Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007012284A1 (de) | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035334A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007063671A1 (de) | 2007-11-13 | 2009-06-25 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
AR072707A1 (es) | 2008-07-09 | 2010-09-15 | Sanofi Aventis | Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
ES2443016T3 (es) | 2009-08-26 | 2014-02-17 | Sanofi | Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8846666B2 (en) | 2011-03-08 | 2014-09-30 | Sanofi | Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP6358942B2 (ja) * | 2014-12-05 | 2018-07-18 | 沢井製薬株式会社 | エンドトキシンの測定用試薬及びエンドトキシンの測定方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2843851A1 (de) * | 1978-10-07 | 1980-04-17 | Bayer Ag | Substituierte n-benzoyl-n'-tert.-alkoxycarbonylphenyl-(thio)-harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als insektizide |
DE3100911A1 (de) * | 1981-01-14 | 1982-08-05 | Basf Ag, 6700 Ludwigshafen | N-benzoyl-n'-phenylharnstoffe und ihre verwendung zur bekaempfung von insekten |
DE3217620A1 (de) * | 1982-05-11 | 1983-11-17 | Bayer Ag, 5090 Leverkusen | 2,5-dihalogenbenzoyl-(thio)harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
DE3217619A1 (de) * | 1982-05-11 | 1983-11-17 | Bayer Ag, 5090 Leverkusen | 2,4-dihalogenbenzoyl-(thio)harnstoffe, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
ATE43788T1 (de) * | 1983-09-01 | 1989-06-15 | Duphar Int Res | Benzoylharnstoffe mit antitumoraler wirkung. |
ATE40111T1 (de) * | 1984-07-05 | 1989-02-15 | Duphar Int Res | Benzoylharnstoffverbindungen sowie solche enthaltende insektizide und akarizide zusammensetzungen. |
AU601145B2 (en) * | 1985-03-01 | 1990-09-06 | Duphar International Research B.V. | Benzoyl urea derivatives having anti-tumor activity |
DE3722155A1 (de) * | 1987-07-04 | 1989-01-12 | Basf Ag | (n-benzoyl-n'-halogenalkoxycarbonylphenyl)-harnstoffe |
MX9709874A (es) * | 1995-06-06 | 1998-03-31 | Pfizer | N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN. |
AR028253A1 (es) * | 2000-03-16 | 2003-04-30 | Pfizer Prod Inc | Inhibidores de la glucogeno fosforilasa |
ATE265424T1 (de) * | 2000-06-09 | 2004-05-15 | Aventis Pharma Gmbh | Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
GB0021831D0 (en) * | 2000-09-06 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
US6677365B2 (en) * | 2001-04-03 | 2004-01-13 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
DE10215908B4 (de) * | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel |
-
2002
- 2002-04-11 DE DE10215907A patent/DE10215907A1/de not_active Withdrawn
- 2002-04-11 IL IL16424902A patent/IL164249A0/xx unknown
-
2003
- 2003-03-28 BR BR0309242-9A patent/BR0309242A/pt not_active IP Right Cessation
- 2003-03-28 CA CA002481817A patent/CA2481817A1/en not_active Abandoned
- 2003-03-28 PL PL03371279A patent/PL371279A1/xx not_active Application Discontinuation
- 2003-03-28 HU HU0500440A patent/HUP0500440A2/hu unknown
- 2003-03-28 UA UA20041109224A patent/UA78040C2/uk unknown
- 2003-03-28 MX MXPA04009468A patent/MXPA04009468A/es unknown
- 2003-03-28 KR KR10-2004-7016158A patent/KR20040097333A/ko not_active Application Discontinuation
- 2003-03-28 EP EP03712111A patent/EP1497262B1/de not_active Expired - Lifetime
- 2003-03-28 RU RU2004133045/04A patent/RU2004133045A/ru not_active Application Discontinuation
- 2003-03-28 CN CNB038081873A patent/CN1286805C/zh not_active Expired - Fee Related
- 2003-03-28 DE DE50312949T patent/DE50312949D1/de not_active Expired - Lifetime
- 2003-03-28 AU AU2003216900A patent/AU2003216900A1/en not_active Abandoned
- 2003-03-28 AT AT03712111T patent/ATE476412T1/de active
- 2003-03-28 JP JP2003582121A patent/JP4328211B2/ja not_active Expired - Fee Related
- 2003-03-28 WO PCT/EP2003/003251 patent/WO2003084922A1/de active Application Filing
- 2003-03-28 OA OA1200400276A patent/OA12805A/fr unknown
- 2003-03-28 NZ NZ535834A patent/NZ535834A/en unknown
- 2003-04-07 PE PE2003000349A patent/PE20040374A1/es not_active Application Discontinuation
- 2003-04-09 AR ARP030101247A patent/AR039403A1/es unknown
- 2003-04-09 PA PA20038570901A patent/PA8570901A1/es unknown
- 2003-04-09 TW TW092108057A patent/TW200404762A/zh unknown
- 2003-04-11 UY UY27761A patent/UY27761A1/es unknown
-
2004
- 2004-09-20 MA MA27867A patent/MA26390A1/fr unknown
- 2004-10-07 HR HR20040930A patent/HRPK20040930B3/xx not_active IP Right Cessation
- 2004-10-08 TN TNP2004000199A patent/TNSN04199A1/en unknown
- 2004-10-08 EC EC2004005347A patent/ECSP045347A/es unknown
- 2004-11-09 NO NO20044882A patent/NO20044882L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003084922A1 (de) | 2003-10-16 |
TNSN04199A1 (en) | 2007-03-12 |
JP4328211B2 (ja) | 2009-09-09 |
DE10215907A1 (de) | 2003-11-06 |
BR0309242A (pt) | 2005-02-09 |
WO2003084922A8 (de) | 2005-01-13 |
MA26390A1 (fr) | 2004-11-01 |
DE50312949D1 (de) | 2010-09-16 |
UA78040C2 (en) | 2007-02-15 |
PA8570901A1 (es) | 2003-11-12 |
RU2004133045A (ru) | 2005-05-27 |
HUP0500440A2 (hu) | 2005-08-29 |
CN1646485A (zh) | 2005-07-27 |
KR20040097333A (ko) | 2004-11-17 |
EP1497262A1 (de) | 2005-01-19 |
CN1286805C (zh) | 2006-11-29 |
TW200404762A (en) | 2004-04-01 |
ATE476412T1 (de) | 2010-08-15 |
OA12805A (fr) | 2006-07-11 |
PL371279A1 (en) | 2005-06-13 |
HRP20040930A2 (en) | 2005-04-30 |
AR039403A1 (es) | 2005-02-16 |
ECSP045347A (es) | 2004-11-26 |
NZ535834A (en) | 2006-07-28 |
IL164249A0 (en) | 2005-12-18 |
PE20040374A1 (es) | 2004-07-20 |
AU2003216900A1 (en) | 2003-10-20 |
CA2481817A1 (en) | 2003-10-16 |
EP1497262B1 (de) | 2010-08-04 |
UY27761A1 (es) | 2003-10-31 |
MXPA04009468A (es) | 2005-01-25 |
NO20044882L (no) | 2004-11-09 |
JP2005522480A (ja) | 2005-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRPK20040930B3 (en) | Acyl-4-carboxyphenylurea derivatives, method for production and use thereof | |
HRPK20041161B3 (en) | N-benzoylureidocinnamate derivatives, method for production and use thereof | |
TR200400185T4 (tr) | PDE 5 inhibitörleri olarak, 8-kuinolinkisantin ve 8-izokuinolinkisantin türevleri. | |
NO20062031L (no) | Derivater av N-[fenyl(alkylptpertdtn-2-yl)metyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske media | |
BR0114986A (pt) | Composto, composição farmacêutica, uso de pelo menos um composto ou um sal, solvato ou hidrato deste farmaceuticamente aceitáveis, e, processo para preparar triazolona partir de uma acil semicarbazida. | |
DK0862567T3 (da) | 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister | |
HUP0202814A2 (hu) | Androgénreceptor moduláló vegyületek és eljárás azok előállítására és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
EA200300622A1 (ru) | Производные амидов тиазолил-, оксазолил, пирролил- и имидазолилкислот, полезные в качестве ингибиторов изоферментов pde4 | |
HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
ES2369837T3 (es) | Compuestos triheterocíclicos como antagonistas de receptor cfr. | |
RS51471B (en) | BIPHYNYLOXYXIC ACID DERIVATIVES FOR TREATMENT OF RESPIRATORY DISEASES | |
RS51044B (sr) | 2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-oni | |
BR9307595A (pt) | Composto, processo para sua preparação, composição herbicida, e, processo para danificar severamente ou exterminar plantas indesejáveis | |
NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
MXPA03010584A (es) | Derivados de tiazol u oxazol que son utiles en el tratamiento de enfermedades cardiovasculares y relacionadas. | |
NO975294D0 (no) | Diaryldiaminderivater og deres anvendelse som delta-opioid (ant)-agonister | |
CA2324418A1 (en) | Novel opiate compounds, methods of making and methods of use | |
DE60137540D1 (de) | Methoden zur behandlung von angstzuständen | |
RS51190B (sr) | Aminoacilni derivati kao prolekovi i lekovi za lečenje tromboembolijskih bolesti | |
CO5160346A1 (es) | Derivados de 3-amino-3-arilpropan-1-ol, su preparacion y uso | |
NO964698L (no) | Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase | |
AR039684A1 (es) | Moduladores de receptor activado de proliferador de peroxisoma con union amida | |
HUP0201357A2 (hu) | Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AKOB | Publication of a request for the grant of a patent not including a substantive examination of a patent application (a consensual patent) | ||
PNAN | Change of the applicant name, address/residence |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE |
|
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20060215 Year of fee payment: 4 |
|
PKB1 | Consensual patent granted | ||
PBKO | Lapse due to non-payment of renewal fee for consensual patent |
Effective date: 20070329 |